closeButton

COVID-19 Vaccine Tracker

  • Phase 1

    Vaccines in small-scale safety trials

    43

  • Phase 2

    Vaccines in expanded safety trials

    48

  • Phase 3

    Vaccines in large-scale efficacy trials

    33

  • Phase 4

    Vaccines Approved for Other Indications/COVID-19

    4

  • Approved

    Emergency Approval / Limited Use

    30

  • Terminated

    Trials which are discontinued by the sponsors

    4

Sr. No. Phase of Trial Country Condition Product Name Intervention Vaccine Type MOA/Technology Sponsor/Collaborators COMPLETION DATE LAUNCH YEAR TRIAL NUMBER TRIAL NAME
1 APPROVED (ARGENTINA, EUROPE, CANADA)-VACCINE SUSPENDED IN FRANCE,GERMANY AND ITALY BRAZIL SARS-COV2 (COVID-19) ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 31-10-2021 Q4 2020 ISRCTN89951424 -
2 APPROVED (CHINA) CHINA SARS-COV2 (COVID-19) CORONAVAC INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 28-08-2020 Q1 2021 NCT04383574 -
3 APPROVED (CHINA) CHINA SARS-COV2 (COVID-19) CORONAVAC INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 10-07-2020 Q1 2021 NCT04352608 -
4 APPROVED (CHINA), EMERGENCY USE (MEXICO, PAKISTAN) CHINA SARS-COV2 (COVID-19) CONVIDECIA RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICS INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY 30-12-2021 Q2 2022 NCT04526990 -
5 APPROVED (CHINA) CHINA SARS-COV2 (COVID-19) - INACTIVATED NOVEL CORONAVIRUS PNEUMONIA VACCINE (VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 11-10-2021 Q1 2021 CHICTR2000031809 -
6 APPROVED (CHINA) CHINA SARS-COV2 (COVID-19) - RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) NON REPLICATING VIRAL VECTOR VECTOR VIRUS ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. 15-09-2021 Q1 2022 NCT04466085 -
7 APPROVED (CHINA) CHINA SARS-COV2 (COVID-19) - NEW CORONAVIRUS VACCINE (CHO CELL) NON REPLICATING VIRAL VECTOR VECTOR VIRUS ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. 01-04-2022 Q4 2022 NCT04646590 -
8 APPROVED (UAE, BAHRAIN, CHINA,HUNGARY) CHINA SARS-COV2 (COVID-19) BBIBP-CorV INACTIVATED NOVEL CORONAVIRUS (2019-COV) VACCINE (VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) BEIJING INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 28-11-2021 Q4 2020 CHICTR2000032459 -
9 APPROVED (EUROPE) GERMANY SARS-COV2 (COVID-19) COMIRNATY BNT162A1, BNT162B1, BNT162B2, BNT162C2 RNA VACCINE A PROTEIN FRAGMENT BIONTECH SE 01-11-2020 Q4 2020 NCT04380701 -
10 APPROVED (UK) GERMANY SARS-COV2 (COVID-19) COMIRNATY 3 LNP-MRNAS RNA VACCINE A PROTEIN FRAGMENT BIONTECH | FOSUN PHARMA |PFIZER 01-10-2020 Q4 2020 2020-001038-36 -
11 APPROVED (INDIA) INDIA SARS-COV2 (COVID-19) COVAXIN INACTIVATED VIRUS WHOLE-VIRION INACTIVATED (COVAXIN) NON REPLICATING VIRAL VECTOR VECTOR VIRUS BHARAT BIOTECH ; NATIONAL INSTITUTE OF VIROLOGY NA Q4 2020 CTRI/2020/07/026300 -
12 APPROVED (INDIA) INDIA SARS-COV2 (COVID-19) BBV152 BBV152 NON REPLICATING VIRAL VECTOR VECTOR VIRUS BHARAT BIOTECH INTERNATIONAL LIMITED|INDIAN COUNCIL OF MEDICAL RESEARCH|IQVIA PTY LTD 30-06-2021 Q4 2020 NCT04641481 -
13 APPROVED (INDIA) INDIA SARS-COV2 (COVID-19) BBV152 BBV152A, BBV152B, BBV152C RNA VACCINE A PROTEIN FRAGMENT BHARAT BIOTECH INTERNATIONAL LIMITED | INDIAN COUNCIL OF MEDICAL RESEARCH 30-06-2021 Q4 2020 NCT04471519 BBV152
14 APPROVED (KAZAKHSTAN) KAZAKHSTAN SARS-COV2 (COVID-19) QazVac QazCovid-in NON REPLICATING VIRAL VECTOR VECTOR VIRUS RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS | NATIONAL SCIENTIFIC CENTER FOR PHTHISIOPULMONOLOGY OF THE REPUBLIC OF KAZAKHSTAN 31-12-2020 Q1 2021 NCT04530357 -
15 APPROVED (RUSSIA, INDIA) RUSSIA SARS-COV2 (COVID-19) SPUTNIK V Gam-COVID-Vac NON REPLICATING VIRAL VECTOR VECTOR VIRUS GAMALEYA RESEARCH INSTITUTE 03-08-2020 Q2 2020 NCT04436471 -
16 APPROVED (RUSSIA) RUSSIA SARS-COV2 (COVID-19) SPUTNIK LIGHT (SINGLE DOSE VACCINE) Gam-COVID-Vac NON REPLICATING VIRAL VECTOR VECTOR VIRUS GAMALEYA RESEARCH INSTITUTE 16-11-2021 Q1 2022 NCT04684446 -
17 APPROVED (CHINA) UAE SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE (VERO CELL) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS | SINOPHARM 15-07-2021 Q3 2020 ChiCTR2000034780 -
18 APPROVED (EUROPE, INDIA, SOUTH AFRICA)-VACCINE SUSPENDED IN FRANCE,GERMANY AND ITALY UNITED KINGDOM SARS-COV2 (COVID-19) AZD1222, ChAdOx1 nCoV-19, COVISHIELD CHADOX1 NCOV-19,MENACWY NON REPLICATING VIRAL VECTOR VECTOR VIRUS THE UNIVERSITY OF OXFORD |'ASTRAZENECA | IQVIA | SERUM INSTITUTE OF INDIA 01-05-2021 Q4 2020 NCT04324606 -
19 APPROVED (EUROPE, SOUTH AFRICA)-VACCINE SUSPENDED IN FRANCE,GERMANY AND ITALY UNITED KINGDOM SARS-COV2 (COVID-19) AZD1222, ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 01-08-2021 Q4 2020 2020-001228-32 -
20 APPROVED (EUROPE, SOUTH AFRICA)-VACCINE SUSPENDED IN FRANCE,GERMANY AND ITALY UNITED KINGDOM SARS-COV2 (COVID-19) AZD1222, ChAdOx1 nCoV-19 CHADOX1-S NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD | ASTRAZENECA 01-05-2021 Q4 2020 PACTR202006922165132, 2020-001072-15 -
21 APPROVED (UK) UNITED KINGDOM SARS-COV2 (COVID-19) AZD1222, ChAdOx1 nCoV-19 CHADOX1 NCOV-19 (ABS 260), MENACWY VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF OXFORD 01-08-2021 Q4 2020 NCT04400838 -
22 APPROVED (USA) USA SARS-COV2 (COVID-19) COMIRNATY BNT162A1, BNT162B1, BNT162B2, BNT162C2 RNA VACCINE A PROTEIN FRAGMENT BIONTECH SE | PFIZER 19-04-2021 Q4 2020 NCT04368728 -
23 APPROVED (USA, ISRAEL, EUROPE) USA SARS-COV2 (COVID-19) MRNA-1273 MRNA-1273 RNA VACCINE A PROTEIN FRAGMENT MODERNA TX, INC. | BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) 27-10-2022 Q4 2020 NCT04470427 -
24 APPROVED (USA, ISRAEL, EUROPE) USA SARS-COV2 (COVID-19) MRNA-1273 MRNA-1273 RNA VACCINE A PROTEIN FRAGMENT MODERNA TX, INC. | BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY 01-08-2021 Q4 2020 NCT04405076 -
25 APPROVED (USA, ISRAEL, EUROPE) USA SARS-COV2 (COVID-19) MRNA-1273 MRNA-1273 RNA VACCINE A PROTEIN FRAGMENT MODERNA TX, INC. | BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY 30-06-2022 Q4 2020 NCT04649151 -
26 APPROVED (CANADA), APPROVED FOR EMERGENCY USE (USA, BAHRAIN) USA SARS-COV2 (COVID-19) JNJ-78436735 (Ad26.COV2-S) Ad26.COV2.S NON REPLICATING VIRAL VECTOR VECTOR VIRUS JOHNSONS AND JOHNSONS 15-09-2021 Q2 2021 NCT04436276 -
27 APPROVED FOR EMERGENCY USE (PHASE 3) BRAZIL SARS-COV2 (COVID-19) CORONAVAC ADSORBED COVID-19 (INACTIVATED) VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SINOVAC 01-09-2021 Q1 2021 NCT04456595 -
28 APPROVED FOR LIMITED USE (PHASE 3) CHINA SARS-COV2 (COVID-19) - RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) NON REPLICATING VIRAL VECTOR VECTOR VIRUS INSITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA OF CHINA | CANSINO BIOLOGICS INC. | JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION | HUBEI PROVINCIAL CENTER FOR DISEA 31-01-2021 Q1 2021 NCT04341389 CTII-NCOV
29 APPROVED FOR EARLY USE (PHASE 3) RUSSIA SARS-COV2 (COVID-19) EpiVacCorona PEPTIDE ANTIGENS INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) VECTOR INSTITUTE 28-09-2020 Q4 2020 NCT04527575 -
30 APPROVED FOR EARLY USE (PHASE 3) RUSSIA SARS-COV2 (COVID-19) CoviVac INACTIVATED CORONAVIRUS INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) CHUMAKOV CENTER (RUSSIAN ACADEMY OF SCIENCES) - Q1 2021 - -
31 TERMINATED AUSTRALIA SARS-COV2 (COVID-19) - MOLECULAR CLAMP STABILIZED SPIKE PROTEIN WITH MF59 ADJUVANT PROTEIN SUBUNIT A PROTEIN FRAGMENT UNIVERSITY OF QUEENSLAND | CSL |SEQIRUS NA Q2 2021 ACTRN12620000674932 -
32 TERMINATED BELGIUM | FRANCE SARS-COV2 (COVID-19) TMV-083 TMV-083 RNA VACCINE A PROTEIN FRAGMENT INSTITUT PASTEUR | THEMIS BIOSCIENCE GMBH | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS 01-11-2020 Q1 2022 NCT04497298 -
33 TERMINATED UNITED KINGDOM SARS-COV2 (COVID-19) COVAC1 LNP-NCOVSARNA RNA VACCINE A PROTEIN FRAGMENT IMPERIAL COLLEGE LONDON 31-07-2021 Q1 2022 ISRCTN17072692 ; 2020-001646-20 COVAC1
34 TERMINATED USA SARS-COV2 (COVID-19) V590 V590 NON REPLICATING VIRAL VECTOR VECTOR VIRUS MERCK SHARP & DOHME CORP. 03-12-2021 Q1 2022 NCT04569786 V590-001
35 PHASE 4 BRAZIL SARS-COV2 (COVID-19) - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE UNIVERSITY OF CAMPINAS, BRAZIL 01-06-2021 Q4 2021 NCT04369794 -
36 PHASE 4 CHINA SARS-COV2 (COVID-19) - INACTIVATED MYCOBACTERIUM VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE GUANGXI MEDICAL UNIVERSITY 12-12-2022 Q2 2023 ChiCTR2000030016 -
37 PHASE 4 GREECE SARS-COV2 (COVID-19) - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS 25-05-2021 Q4 2021 NCT04414267 ACTIVATE II
38 PHASE 4 USA SARS-COV2 (COVID-19) - VACCINATED WITH POLIO VACCINE (IPV) REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE E-MO BIOLOGY INC 15-01-2021 Q4 2021 NCT04639375 -
39 PHASE 3 UAE SARS-COV2 (COVID-19) GAM-COVID-VAC GAM-COVID-VAC NON REPLICATING VIRAL VECTOR VECTOR VIRUS GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY | HEALTH MINISTRY OF THE RUSSIAN FEDERATION|PDC-CRO 01-08-2021 Q2 2022 NCT04656613 SPUTNIK-UAE
40 PHASE 3 CANADA SARS-COV2 (COVID-19) VPM1002 VPM1002 NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY HEALTH NETWORK, TORONTO | SERUM INSTITUTE OF INDIA PVT. LTD. | MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY | VERITY PHARMACEUTICALS | BILL GATES FOUNDATION 01-06-2021 Q1 2022 NCT04439045 COBRA
41 PHASE 3 CANADA SARS-COV2 (COVID-19) - CORONAVIRUS-LIKE PARTICLE COVID-19 VACCINE (PLANT DERIVED VLP) RNA VACCINE A PROTEIN FRAGMENT MEDICAGO;'GSK;'DYNAVAX 30-04-2021 Q4 2021 NCT04450004 -
42 PHASE 3 AUSTRALIA SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS MURDOCH CHILDRENS RESEARCH INSTITUTE | ROYAL CHILDREN'S HOSPITAL 30-06-2021 Q4 2021 NCT04327206 BRACE
43 PHASE 3 BAHRAIN SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE (VERO CELL) NON REPLICATING VIRAL VECTOR VECTOR VIRUS CHINA NATIONAL BIOTEC GROUP COMPANY LIMITED | G42 HEALTHCARE COMPANY|ABU DHABI HEALTH SERVICES COMPANY | WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD | BEIJING INSTITUTE OF BIOLOGICAL PRODUCTS CO., 16-03-2021 Q4 2021 NCT04510207 COVID-19
44 PHASE 3 CUBA SARS-COV2 (COVID-19) SOBERANA 2 CORONAVIRUS SPIKE PROTEIN FUSED WITH TETANUS VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT FINLAY VACCINE INSTITUTE - Q4 2022 RPCEC00000354-Sp -
45 PHASE 3 CUBA SARS-COV2 (COVID-19) ABDALA CIGB-66 RNA VACCINE A PROTEIN FRAGMENT CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (CIGB) - Q3 2022 IG/CIGB-66I/CVD19/2002 -
46 PHASE 3 COLOMBIA SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS UNIVERSITY OF ANTIOQUIA 01-06-2021 Q4 2021 NCT04362124 -
47 PHASE 3 DENMARK SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS BANDIM HEALTH PROJECT | UNIVERSITY OF SOUTHERN DENMARK 01-01-2021 Q3 2021 NCT04373291 -
48 PHASE 3 EGYPT SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS AIN SHAMS UNIVERSITY 01-10-2020 Q2 2021 NCT04350931 -
49 PHASE 3 EGYPT SARS-COV2 (COVID-19) - MEASLES-MUMPS-RUBELLA VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS KASR EL AINI HOSPITAL 01-10-2020 Q2 2021 NCT04357028 -
50 PHASE 3 FRANCE SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS ASSISTANCE PUBLIQUE - H'PITAUX DE PARIS 11-02-2021 Q4 2021 NCT04384549 -
51 PHASE 3 GERMANY SARS-COV2 (COVID-19) VPM1002 VPM1002 NON REPLICATING VIRAL VECTOR VECTOR VIRUS VAKZINE PROJEKT MANAGEMENT GMBH | FGK CLINICAL RESEARCH GMBH 31-05-2021 Q1 2022 NCT04435379 -
52 PHASE 3 GERMANY SARS-COV2 (COVID-19) VPM1002 VPM1002 NON REPLICATING VIRAL VECTOR VECTOR VIRUS VAKZINE PROJEKT MANAGEMENT GMBH | FGK CLINICAL RESEARCH GMBH 30-06-2021 Q1 2022 NCT04387409 -
53 PHASE 3 GERMANY SARS-COV2 (COVID-19) CVnCoV CVnCoV NON REPLICATING VIRAL VECTOR VECTOR VIRUS CUREVAC 01-11-2021 Q2 2021 NCT04515147 -
54 PHASE 3 GERMANY SARS-COV2 (COVID-19) CVnCoV CVnCoV NON REPLICATING VIRAL VECTOR VECTOR VIRUS CUREVAC AG 30-06-2021 Q1 2023 NCT04674189 -
55 PHASE 3 INDIA SARS-COV2 (COVID-19) ZYCOV-D DNA-BASED DNA PLASMID (ZYCOV-D) RNA VACCINE A PROTEIN FRAGMENT ZYDUS CADILA HEALTHCARE LIMITED NA Q2 2021 CTRI/2020/07/026352 -
56 PHASE 3 IRAN SARS-COV2 (COVID-19) COVIran Barekat INACTIVATED CORONAVIRUS INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SHAFA PHARMED PARS NA Q2 2021 - -
57 PHASE 3 MEXICO SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS HOSPITAL UNIVERSITARIO DR. JOSE E. GONZALEZ 01-01-2021 Q4 2021 NCT04461379 -
58 PHASE 3 POLAND SARS-COV2 (COVID-19) BCG-10 VACCINE BCG-10 VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS HANNA CZAJKA|MEDICAL RESEARCH AGENCY - AGENCJA BADA' | MEDYCZNYCH|UNIVERSITY OF RZESZOW 01-12-2020 Q2 2021 NCT04648800 -
59 PHASE 3 RUSSIA SARS-COV2 (COVID-19) - ADENOVIRUS TYPE 5 VECTOR NON REPLICATING VIRAL VECTOR VECTOR VIRUS NPO PETROVAX | CANSINO BIOLOGICS INC. 30-11-2020 Q2 2021 NCT04540419 -
60 PHASE 3 SOUTH AFRICA SARS-COV2 (COVID-19) - BCG VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS TASK APPLIED SCIENCE 28-04-2021 Q4 2021 NCT04379336 -
61 PHASE 3 SPAIN SARS-COV2 (COVID-19) RUTI RUTIA VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS PERE-JOAN CARDONA | FUNDACIó INSTITUT GERMANS TRIAS I PUJOL 20-12-2020 Q3 2021 NCT04453488 -
62 PHASE 3 UNITED KINGDOM SARS-COV2 (COVID-19) - SARS-COV-2 RS NON REPLICATING VIRAL VECTOR VECTOR VIRUS NOVAVAX 01-01-2021 Q4 2021 NCT04583995 -
63 PHASE 3 UNITED KINGDOM SARS-COV2 (COVID-19) VLA2001 VERO-CELL BASED INACTIVATED VIRUS RNA VACCINE A PROTEIN FRAGMENT VALNEVA 16-12-2020 Q2 2021 NA -
64 PHASE 3 USA SARS-COV2 (COVID-19) - BCG VACCINE REPURPOSED VACCINES MULTIDISEASE/MULTIPATHOGEN VECTOR VACCINE TEXAS A&M UNIVERSITY | BAYLOR COLLEGE OF MEDICINE | M.D. ANDERSON CANCER CENTER | CEDARS-SINAI MEDICAL CENTER | HARVARD UNIVERSITY 01-05-2021 Q4 2021 NCT04348370 BADAS
65 PHASE 3 USA SARS-COV2 (COVID-19) - ORAL POLIO VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS NEUROACTIVA, INC.|BIOMED INDUSTRIES, INC. 01-11-2022 Q2 2023 NCT04540185 OPV-NA831
66 PHASE 3 USA SARS-COV2 (COVID-19) NVX-CoV2373 RECOMBINANT SARS COV-2 GLYCOPROTEIN NON REPLICATING VIRAL VECTOR VECTOR VIRUS NOVAVAX 01-12-2020 Q1 2021 NCT04368988 -
67 PHASE 2| PHASE 3 AUSTRALIA SARS-COV2 (COVID-19) SCB-2019 SCB-2019 NON REPLICATING VIRAL VECTOR VECTOR VIRUS CLOVER BIOPHARMACEUTICALS AUS PTY LTD | GLAXOSMITHKLINE | 'SANOFI 20-10-2020 Q4 2021 NCT04405908 -
68 PHASE 2| PHASE 3 GERMANY SARS-COV2 (COVID-19) GRAD-COV2 GORILLA-DERIVED REPLICATION-DEFECTIVE ADENOVIRAL VECTOR PROTEIN SUBUNIT A PROTEIN FRAGMENT REITHERA | LEUKOCARE 01-12-2021 Q1 2021 NA -
69 PHASE 2| PHASE 3 INDIA SARS-COV2 (COVID-19) GAM-COVID-VAC GAM-COVID-VAC NON REPLICATING VIRAL VECTOR VECTOR VIRUS DR. REDDY'S LABORATORIES LIMITED | GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY | HEALTH MINISTRY OF THE RUSSIAN FEDERATION | CRO: JSS MEDICAL RESEARCH INDIA PVT. LTD. 01-08-2021 Q2 2022 NCT04640233 -
70 PHASE 2| PHASE 3 USA SARS-COV2 (COVID-19) UB-612 UB-612 NON REPLICATING VIRAL VECTOR VECTOR VIRUS COVAXX|DIAGNóSTICOS DA AMERICA 22-03-2023 Q4 2023 NCT04683224 -
71 PHASE 2| PHASE 3 USA SARS-COV2 (COVID-19) INO-4800 INO-4800 DNA VACCINE A PROTEIN FRAGMENT INOVIO PHARMACEUTICALS 02-09-2022 Q2 2023 NCT04642638 -
72 PHASE 2 AZERBAIJAN SARS-COV2 (COVID-19) AZD1222 AZD1222 NON REPLICATING VIRAL VECTOR VECTOR VIRUS R-PHARM | ASTRAZENECA 09-04-2021 Q1 2022 NCT04686773 -
73 PHASE 2 CHINA SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) WEST CHINA SECOND UNIVERSITY HOSPITAL | YUNNAN CENTER FOR DISEASE CONTROL AND PREVENTION | CHINESE ACADEMY OF MEDICAL SCIENCES 01-09-2020 Q2 2021 NCT04412538 -
74 PHASE 2 CHINA SARS-COV2 (COVID-19) 2019-nCOV RECOMBINANT NOVEL CORONAVIRUS (2019-NCOV) VACCINE NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICAL INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY 31-01-2021 Q3 2021 CHICTR2000031781 -
75 PHASE 2 CHINA SARS-COV2 (COVID-19) - RECOMBINANT NEW CORONAVIRUS VACCINE (Sf9 CELL) PROTEIN SUBUNIT A PROTEIN FRAGMENT WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY 16-11-2021 Q1 2022 ChiCTR2000039994 -
76 PHASE 2 CHINA SARS-COV2 (COVID-19) - RECOMBINANT COVID-19 VACCINE (SF9 CELLS) PROTEIN SUBUNIT A PROTEIN FRAGMENT JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION | WEST CHINA HOSPITAL 18-02-2021 Q4 2021 NCT04640402 -
77 PHASE 2 CHINA SARS-COV2 (COVID-19) - ADENOVIRUS TYPE 5 VECTOR NON REPLICATING VIRAL VECTOR VECTOR VIRUS CANSINO BIOLOGICS INC.|BEIJING INSTITUTE OF BIOTECHNOLOGY|JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION 21-08-2021 Q3 2022 NCT04566770 -
78 PHASE 2 CHINA SARS-COV2 (COVID-19) BNT162B2 BNT162B2 RNA VACCINE A PROTEIN FRAGMENT BIONTECH SE | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO, LTD. 01-12-2021 Q3 2022 NCT04649021 -
79 PHASE 2 CHINA SARS-COV2 (COVID-19) Ad5-nCoV RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) RNA VACCINE A PROTEIN FRAGMENT CANSINO BIOLOGICS INC. | INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES. PLA OF CHINA | JIANGSU PROVINCE CENTERS FOR DISEASE CONTROL AND PREVENTION | HUBEI PROVINCIAL CENTER FOR DISE 30-12-2020 Q2 2021 NCT04313127 CTCOVID-19
80 PHASE 2 CHINA SARS-COV2 (COVID-19) - SARS-COV-2 VACCINE (CHO CELL) PROTEIN SUBUNIT A PROTEIN FRAGMENT ZHONGYIANKE BIOTECH 07-04-2021 Q3 2022 NCT04636333 -
81 PHASE 2 CUBA SARS-COV2 (COVID-19) SOBERANA PLUS RBD SPIKE PROTEIN RNA VACCINE A PROTEIN FRAGMENT FINLAY VACCINE INSTITUTE 11-01-2021 Q2 2021 RPCEC00000366 -
82 PHASE 2 ISRAEL SARS-COV2 (COVID-19) BRILIFE VESICULAR STOMATITIS VIRUSES PROTEIN SUBUNIT A PROTEIN FRAGMENT ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH 01-11-2021 Q2 2022 NA -
83 PHASE 2 KOREA SARS-COV2 (COVID-19) GX-19 DNA VACCINE (GX-19) RNA VACCINE A PROTEIN FRAGMENT GENEXINE CONSORTIUM 17-03-2021 Q1 2021 NCT04445389 -
84 PHASE 2 RUSSIA SARS-COV2 (COVID-19) GAM-COVID-VAC GAM-COVID-VAC RNA VACCINE A PROTEIN FRAGMENT GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY | HEALTH MINISTRY OF THE RUSSIAN FEDERATION 30-12-2020 Q2 2021 NCT04587219 -
85 PHASE 2 SINGAPORE SARS-COV2 (COVID-19) LUNAR-COV19 LUNAR-COV19 RNA VACCINE A PROTEIN FRAGMENT ARCTURUS THERAPEUTICS AND DUKENUS 01-12-2020 Q3 2021 NCT04480957 -
86 PHASE 2 SOUTH AFRICA SARS-COV2 (COVID-19) SARS-COV-2 RS SARS-COV-2 RS RNA VACCINE A PROTEIN FRAGMENT NOVAVAX | BILL AND MELINDA GATES FOUNDATION 01-11-2021 Q3 2022 NCT04533399 -
87 PHASE 2 TAIWAN SARS-COV2 (COVID-19) MVC-COV1901 MVC-COV1901 PROTEIN SUBUNIT A PROTEIN FRAGMENT MEDIGEN VACCINE BIOLOGICS CORP. 30-05-2021 Q4 2021 NCT04487210 -
88 PHASE 2 TAIWAN SARS-COV2 (COVID-19) UB-612 UB-612 PROTEIN SUBUNIT A PROTEIN FRAGMENT COVAXX | UNITED BIOMEDICAL INC., ASIA 31-12-2020 Q1 2021 NCT04545749 -
89 PHASE 2 TURKEY SARS-COV2 (COVID-19) ERUCOV-VAC INACTIVE VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) ERCIYES UNIVERSITY | KOCAK PHARMA NA Q1 2022 NA -
90 PHASE 2 UNITED KINGDOM SARS-COV2 (COVID-19) SNG001 INTERFERON BETA (IFN-') RNA VACCINE A PROTEIN FRAGMENT SYNAIRGEN RESEARCH LTD. 01-02-2021 Q2 2021 NCT04385095 -
91 PHASE 2 UNITED KINGDOM | FRANCE SARS-COV2 (COVID-19) - RECOMBINANT PROTEIN-BASED VACCINE RNA VACCINE A PROTEIN FRAGMENT SANOFI | GSK 01-11-2020 Q2 2021 NCT04537208 -
92 PHASE 2 USA SARS-COV2 (COVID-19) INO-4800 INO-4800, DEVICE: CELLECTRA' 200 RNA VACCINE A PROTEIN FRAGMENT INTERNATIONAL VACCINE INSTITUTE | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS | INOVIO PHARMACEUTICALS 22-02-2022 Q1 2022 NCT04447781 -
93 PHASE 2 VIETNAM SARS-COV2 (COVID-19) - NA NA NA NANOGEN NA NA NA -
94 PHASE 1B|PHASE 2B CHINA SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE RNA VACCINE A PROTEIN FRAGMENT CHINESE ACADEMY OF MEDICAL SCIENCES | WEST CHINA SECOND UNIVERSITY HOSPITAL | YUNNAN CENTER FOR DISEASE CONTROL AND PREVENTION 01-11-2020 Q2 2021 NCT04470609 -
95 PHASE 1B|PHASE 2 USA SARS-COV2 (COVID-19) AV-COVID-19 AV-COVID-19 RNA VACCINE A PROTEIN FRAGMENT AIVITA BIOMEDICAL, INC. 01-12-2020 Q2 2021 NCT04386252 -
96 PHASE 1|PHASE 2 CANADA SARS-COV2 (COVID-19) COVAC COVAC-2 RNA VACCINE A PROTEIN FRAGMENT Vaccine and Infectious Disease Organization (VIDO) 01-10-2023 Q2 2023 NCT04702178 -
97 PHASE 1|PHASE 2 CANADA SARS-COV2 (COVID-19) - V-SARS RNA VACCINE A PROTEIN FRAGMENT IMMUNITOR LLC 15-05-2021 Q4 2021 NCT04380532 -
98 PHASE 1|PHASE 2 CANADA SARS-COV2 (COVID-19) Ad5-nCoV RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) RNA VACCINE A PROTEIN FRAGMENT CANSINO BIOLOGICS INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY | CANADIAN CENTER FOR VACCINOLOGY 30-12-2021 Q1 2022 NCT04398147 -
99 PHASE 1|PHASE 2 CANADA SARS-COV2 (COVID-19) VBI-2902a ENVELOPED VIRUS-LIKE PARTICLE (EVLP) OF SARS-COV-2 SPIKE (S) GLYCOPROTEIN INACTIVATED VIRUS A PROTEIN FRAGMENT VBI VACCINES INC. 01-06-2022 Q4 2022 NCT04773665 -
100 PHASE 1|PHASE 2 CHINA SARS-COV2 (COVID-19) SYNTHETIC MINIGENE VACCINE LV-SMENP-DC VACCINE AND ANTIGEN-SPECIFIC CTLS RNA VACCINE A PROTEIN FRAGMENT SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE | SHENZHEN THIRD PEOPLE'S HOSPITAL | SHENZHEN SECOND PEOPLE'S HOSPITAL 31-07-2023 Q4 2024 NCT04276896 -
101 PHASE 1|PHASE 2 CHINA SARS-COV2 (COVID-19) - GENETICALLY ENGINEERED SPIKE PROTEIN RNA VACCINE A PROTEIN FRAGMENT SINOPHARM 30-12-2021 Q1 2022 - -
102 PHASE 1|PHASE 2 CHINA SARS-COV2 (COVID-19) - RECOMBINANT SARS-COV-2 VACCINE (CHO CELL) RNA VACCINE A PROTEIN FRAGMENT LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD | NATIONAL VACCINE AND SERUM INSTITUTE, CHINA 25-10-2022 Q2 2023 NCT04869592 -
103 PHASE 1|PHASE 2 GERMANY SARS-COV2 (COVID-19) BNT162B3 BNT162B3 RNA VACCINE A PROTEIN FRAGMENT BIONTECH RNA PHARMACEUTICALS GMBH | BIONTECH SE 01-09-2021 Q3 2022 NCT04537949 -
104 PHASE 1|PHASE 2 INDIA SARS-COV2 (COVID-19) HGC019 mRNA VACCINE RNA VACCINE A PROTEIN FRAGMENT GENNOVA BIOPHARMACEUTICALS | HDT BIO NA Q4 2021 NA -
105 PHASE 1|PHASE 2 ITALY SARS-COV2 (COVID-19) COVID-eVax DNA FRAGMENT DNA VACCINE A PROTEIN FRAGMENT TAKIS | ROTTAPHARM BIOTECH NA Q4 2021 NA -
106 PHASE 1|PHASE 2 ITALY SARS-COV2 (COVID-19) - MRNA COVID-19 VACCINE RNA VACCINE A PROTEIN FRAGMENT SANOFI | TRANSLATE BIO NA Q2 2022 NA -
107 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) DS-5670 mRNA VACCINE RNA VACCINE A PROTEIN FRAGMENT DAIICHI SANKYO|UNIVERSITY OF TOKYO NA Q4 2022 NA -
108 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) TAK-919 TAK-919 RNA VACCINE A PROTEIN FRAGMENT TAKEDA 11-03-2022 Q4 2022 NCT04677660 -
109 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) AG0301-COVID19 AG0301-COVID19 RNA VACCINE A PROTEIN FRAGMENT OSAKA UNIVERSITY | ANGES | TAKARA BIO 26-09-2020 Q2 2021 NCT04463472, JapicCTI-205328 -
110 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) S-268019 RECOMBINANT PROTEIN VACCINE RNA VACCINE A PROTEIN FRAGMENT SHIONOGI NA Q4 2021 NA -
111 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) KD-414 RECOMBINANT PROTEIN VACCINE RNA VACCINE A PROTEIN FRAGMENT KM BIOLOGICS CO NA NA NA -
112 PHASE 1|PHASE 2 JAPAN SARS-COV2 (COVID-19) EXG-5003 COVID-19 SELF-REPLICATING MRNA VACCINE INTRADERMAL RNA VACCINE A PROTEIN FRAGMENT FUJITA HEALTH UNIVERSITY | ELIXIRGEN THERAPEUTICS, INC. 31-01-2023 Q4 2023 NCT04863131 -
113 PHASE 1|PHASE 2 NETHERLANDS SARS-COV2 (COVID-19) PREVENT-nCoV ABNCOV2 VACCINE RNA VACCINE A PROTEIN FRAGMENT BAVARIAN NORDIC - Q1 2023 NA -
114 PHASE 1|PHASE 2 SOUTH AFRICA SARS-COV2 (COVID-19) AZD1222 CHADOX1 NCOV-19 RNA VACCINE A PROTEIN FRAGMENT UNIVERSITY OF WITWATERSRAND, SOUTH AFRICA | MEDICAL RESEARCH COUNCIL, SOUTH AFRICA | BILL AND MELINDA GATES FOUNDATION | UNIVERSITY OF OXFORD 01-10-2020 Q4 2020 NCT04444674 -
115 PHASE 1|PHASE 2 SOUTH KOREA SARS-COV2 (COVID-19) AdCLD-CoV19 AdCLD-CoV19 RNA VACCINE A PROTEIN FRAGMENT CELLID 01-04-2021 Q4 2021 NCT04666012 -
116 PHASE 1|PHASE 2 SOUTH KOREA SARS-COV2 (COVID-19) GBP510 GBP510 RNA VACCINE A PROTEIN FRAGMENT SK BIOSCIENCE 01-08-2021 Q4 2021 NCT04742738 -
117 PHASE 1|PHASE 2 SOUTH KOREA SARS-COV2 (COVID-19) EuCorVac-19 CORONAVIRUS SPIKE PROTEIN RNA VACCINE A PROTEIN FRAGMENT EUBIOLOGICS 01-06-2021 Q2 2022 - -
118 PHASE 1|PHASE 2 USA SARS-COV2 (COVID-19) KBP-COVID-19 KBP-COVID-19 (RBD-based vaccine) RNA VACCINE A PROTEIN FRAGMENT KENTUCKY BIOPROCESSING, INC 25-01-2021 Q4 2021 NCT04473690 -
119 PHASE 1|PHASE 2 USA SARS-COV2 (COVID-19) AKS-452 CORONAVIRUS SPIKE PROTEIN RNA VACCINE A PROTEIN FRAGMENT AKSTON BIOSCIENCES - - - -
120 PHASE 1 AUSTRALIA SARS-COV2 (COVID-19) - HEPATITIS B SURFACE ANTIGEN (HBSAG) VIRUS LIKE PARTICLE (VLP) RNA VACCINE A PROTEIN FRAGMENT SPYBIOTECH | SERUM INSTITUTE OF INDIA PVT LTD 30-03-2021 Q1 2022 ACTRN12620000817943 -
121 PHASE 1 AUSTRALIA SARS-COV2 (COVID-19) COVAX-19 COVID19 VACCINE RNA VACCINE A PROTEIN FRAGMENT VAXINE PTY LTD | CENTRAL ADELAIDE LOCAL HEALTH NETWORK INCORPORATED 01-07-2020 Q1 2021 NCT04453852 COVAX-19
122 PHASE 1 AUSTRALIA SARS-COV2 (COVID-19) COVIGEN DNA-BASED VACCINE DNA VACCINE A PROTEIN FRAGMENT BIONET CO., LTD | TECHNOVALIA 30-06-2022 Q4 2022 NCT04742842 COVALIA
123 PHASE 1 CANADA SARS-COV2 (COVID-19) - bacTRL-Spike RNA VACCINE A PROTEIN FRAGMENT SYMVIVO CORPORATION 31-08-2021 Q2 2021 NCT04334980 -
124 PHASE 1 CANADA SARS-COV2 (COVID-19) Covigenix VAX-001 PLASMID DNA VACCINE RNA VACCINE A PROTEIN FRAGMENT ENTOS PHARMACEUTICALS INC. 01-06-2021 Q4 2021 NCT04591184 -
125 PHASE 1 CANADA SARS-COV2 (COVID-19) PTX-COVID19-B mRNA vaccine RNA VACCINE A PROTEIN FRAGMENT PROVIDENCE THERAPEUTICS 01-12-2021 Q2 2022 - -
126 PHASE 1 CUBA SARS-COV2 (COVID-19) SOBERANA 1 PROTEINS FROM A BACTERIA RNA VACCINE A PROTEIN FRAGMENT FINLAY VACCINE INSTITUTE 30-10-2020 Q4 2021 IFV/COR/04 -
127 PHASE 1 CHINA SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE(VERO CELLS) RNA VACCINE A PROTEIN FRAGMENT LI GUIFAN 02-10-2020 Q4 2021 CHICTR2000038804 -
128 PHASE 1 CHINA SARS-COV2 (COVID-19) 2019-COV RECOMBINANT NOVEL CORONAVIRUS (2019-COV) VACCINE RNA VACCINE A PROTEIN FRAGMENT CANSINO BIOLOGICAL INC. | BEIJING INSTITUTE OF BIOTECHNOLOGY 01-12-2020 Q2 2021 CHICTR2000030906 -
129 PHASE 1 CHINA SARS-COV2 (COVID-19) BNT162B1 BNT162B1 RNA VACCINE A PROTEIN FRAGMENT JIANGSU PROVINCIAL CENTER FOR DISEASE PREVENTION AND CONTROL 01-08-2020 Q1 2021 ChiCTR2000034825 -
130 PHASE 1 CHINA SARS-COV2 (COVID-19) - RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) RNA VACCINE A PROTEIN FRAGMENT ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. | THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY | BEIJING CHAO YANG HOSPITAL 21-07-2021 Q4 2021 NCT04445194 -
131 PHASE 1 CHINA SARS-COV2 (COVID-19) - PATHOGEN-SPECIFIC AAPC RNA VACCINE A PROTEIN FRAGMENT SHENZHEN GENO-IMMUNE MEDICAL INSTITUTE | SHENZHEN THIRD PEOPLE'S HOSPITAL | SHENZHEN SECOND PEOPLE'S HOSPITAL 31-07-2023 Q4 2024 NCT04299724 -
132 PHASE 1 CHINA SARS-COV2 (COVID-19) - INACTIVATED SARS-COV-2 VACCINE (VERO CELLS) INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD 30-06-2021 Q1 2022 NCT04756323 -
133 PHASE 1 CHINA SARS-COV2 (COVID-19) - RNA-BASED VACCINE MRNA RNA VACCINE A PROTEIN FRAGMENT PEOPLE'S LIBERATION ARMY (PLA) ACADEMY OF MILITARY SCIENCES | WALVAX BIOTECH 31-12-2021 Q2 2022 CHICTR2000034112 -
134 PHASE 1 CHINA SARS-COV2 (COVID-19) - MicroRNA2911 RNA VACCINE A PROTEIN FRAGMENT IMMUNITOR LLC 31-08-2020 Q3 2021 ChiCTR2000031432 -
135 PHASE 1 CHINA SARS-COV2 (COVID-19) - RECOMBINANT NEW CORONAVIRUS VACCINE (CHO CELL) RNA VACCINE A PROTEIN FRAGMENT ANHUI ZHIFEI LONGCOM BIOLOGIC PHARMACY CO., LTD. 31-10-2021 Q3 2022 NCT04550351 -
136 PHASE 1 CHINA SARS-COV2 (COVID-19) BNT162B1 BNT162B1 RNA VACCINE A PROTEIN FRAGMENT BIONTECH RNA PHARMACEUTICALS GMBH | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO, LTD. | BIONTECH SE 30-09-2020 Q1 2021 NCT04523571 -
137 PHASE 1 CHINA SARS-COV2 (COVID-19) ReCOV RECOMBINANT TWO-COMPONENT COVID-19 VACCINE (CHO CELL) RNA VACCINE A PROTEIN FRAGMENT JIANGSU REC-BIOTECHNOLOGY CO., LTD. 01-07-2021 Q4 2022 NCT04818801 -
138 PHASE 1 FRANCE SARS-COV2 (COVID-19) CoVepiT SARS-COV-2 VACCINE ACTIVATING T CELLS RNA VACCINE A PROTEIN FRAGMENT OSE IMMUNOTHERAPEUTICS - - - -
139 PHASE 1 GERMANY SARS-COV2 (COVID-19) CVnCoV CVNCOV VACCINE RNA VACCINE A PROTEIN FRAGMENT CUREVAC AG | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) 01-08-2021 Q2 2021 NCT04449276 -
140 PHASE 1 GERMANY SARS-COV2 (COVID-19) - MULTIPEPTIDE COCKTAIL PROTEIN SUBUNIT A PROTEIN FRAGMENT UNIVERSITY OF TU'BINGEN 30-09-2021 Q2 2022 NCT04546841 -
141 PHASE 1 GERMANY SARS-COV2 (COVID-19) MVA-SARS-2-S MVA-SARS-2-S PROTEIN SUBUNIT A PROTEIN FRAGMENT GERMAN CENTER FOR INFECTION RESEARCH | UNIVERSIT'TSKLINIKUM HAMBURG-EPPENDORF 01-05-2021 Q4 2021 NCT04569383 -
142 PHASE 1 IRAN SARS-COV2 (COVID-19) - Razi Cov Pars PROTEIN SUBUNIT A PROTEIN FRAGMENT RAZI VACCINE & SERUM RESEARCH INSTITUTE - Q4 2021 52975 -
143 PHASE 1 INDIA SARS-COV2 (COVID-19) BBV154 ADENOVIRUS VECTORED COVID-19 NON REPLICATING VIRAL VECTOR VECTOR VIRUS BHARAT BIOTECH INTERNATIONAL LIMITED 01-05-2021 Q2 2022 NCT04751682 -
144 PHASE 1 NOT STATED SARS-COV2 (COVID-19) COVAX-19 COVAX-19 PROTEIN SUBUNIT A PROTEIN FRAGMENT GENECURE BIOTECHNOLOGIES 01-07-2021 Q1 2022 NCT04428073 -
145 PHASE 1 SOUTH KOREA SARS-COV2 (COVID-19) GLS-5310 GLS-5310 DNA VACCINE A PROTEIN FRAGMENT GENEONE LIFE SCIENCE, INC 31-07-2022 Q4 2022 NCT04673149 -
146 PHASE 1 TAIWAN SARS-COV2 (COVID-19) AdimrSC-2f AdimrSC-2f PROTEIN SUBUNIT A PROTEIN FRAGMENT ADIMMUNE CORPORATION 20-11-2020 Q4 2021 NCT04522089 -
147 PHASE 1 THAILAND SARS-COV2 (COVID-19) ChulaCov19 RNA-BASED VACCINE MRNA RNA VACCINE A PROTEIN FRAGMENT CHULA VACCINE RESEARCH CENTER | CHULALONGKORN UNIVERSITY 01-03-2021 Q3 2021 NCT04566276 -
148 PHASE 1 THAILAND SARS-COV2 (COVID-19) - NDV-HXP-S VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | MAHIDOL UNIVERSITY 01-04-2022 Q4 2022 NCT04764422 -
149 PHASE 1 TURKEY SARS-COV2 (COVID-19) - SARS-COV-2 VLP VACCINE INACTIVATED VIRUS A PROTEIN FRAGMENT SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY | MIDDLE EAST TECHNICAL UNIVERSITY | BILKENT UNIVERSITY 01-01-2022 Q4 2022 NCT04818281 -
150 PHASE 1 TURKEY SARS-COV2 (COVID-19) KO'AK-19 KO'AK-19 INAKTIF ADJUVANLI COVID-19 VACCINE INACTIVATED VIRUS A PROTEIN FRAGMENT KOCAK FARMA 01-06-2021 Q2 2022 NCT04838080 -
151 PHASE 1 TURKEY SARS-COV2 (COVID-19) - SARS-COV-2 VACCINE INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) SCIENTIFIC AND TECHNOLOGICAL RESEARCH COUNCIL OF TURKEY 01-10-2021 Q2 2022 NCT04866069 -
152 PHASE 1 UNITED KINGDOM SARS-COV2 (COVID-19) COVI-VAC COVI-VAC INACTIVATED VIRUS LIVE VIRUS (ATTENUATED) CODAGENIX, INC 01-06-2021 Q1 2022 NCT04619628 -
153 PHASE 1 USA SARS-COV2 (COVID-19) MRNA-1273 MRNA-1273 RNA VACCINE A PROTEIN FRAGMENT NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) 22-11-2021 Q2 2021 NCT04283461 -
154 PHASE 1 USA SARS-COV2 (COVID-19) VXA-CoV2-1 VXA-CoV2-1 NON REPLICATING VIRAL VECTOR VECTOR VIRUS VAXART 01-12-2020 Q2 2021 NCT04563702 -
155 PHASE 1 USA SARS-COV2 (COVID-19) - hAd5-S-FUSION+N-ETSD VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT IMMUNITYBIO, INC. 19-11-2021 Q2 2022 NCT04591717 -
156 PHASE 1 USA SARS-COV2 (COVID-19) V591 V591 NON REPLICATING VIRAL VECTOR VECTOR VIRUS MERCK SHARP & DOHME CORP. 26-04-2022 Q3 2022 NCT04498247 V591-001
157 PHASE 1 USA SARS-COV2 (COVID-19) CORVax SPIKE (S) PROTEIN PLASMID DNA DNA VACCINE A PROTEIN FRAGMENT PROVIDENCE HEALTH & SERVICES | ONCOSEC IMMUNOTHERAPIES 01-05-2021 Q4 2021 NCT04627675 -
158 PHASE 1 USA SARS-COV2 (COVID-19) COH04S1 SYNTHETIC MVA-BASED COH04S1 NON REPLICATING VIRAL VECTOR VECTOR VIRUS CITY OF HOPE MEDICAL CENTER | NATIONAL CANCER INSTITUTE (NCI) 10-11-2022 Q2 2023 NCT04639466 -
159 PHASE 1 USA SARS-COV2 (COVID-19) AdCOVID AD5 ADENOVIRUS PROTEIN SUBUNIT A PROTEIN FRAGMENT ALTIMMUNE, INC. 01-02-2022 Q4 2022 NCT04679909 -
160 PHASE 1 USA SARS-COV2 (COVID-19) INO-4800 INO-4800, DEVICE: CELLECTRA' 200 DNA VACCINE A PROTEIN FRAGMENT INOVIO PHARMACEUTICALS | COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) 01-07-2021 Q2 2021 NCT04336410 -
161 PHASE 1 USA SARS-COV2 (COVID-19) - CHIMPANZEE ADENOVIRUS MRNA PRIME-BOOST PROPHYLACTIC VACCINE PROTEIN SUBUNIT A PROTEIN FRAGMENT GRITSTONE ONCOLOGY | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 19-09-2022 Q2 2023 NCT04776317 -
162 PHASE 1 USA SARS-COV2 (COVID-19) SpFN SARS-COV-2-SPIKE-FERRITIN-NANOPARTICLE PROTEIN SUBUNIT A PROTEIN FRAGMENT WALTER REED ARMY INSTITUTE OF RESEARCH 30-10-2022 Q2 2023 NCT04784767 -
Get In Touch

To request for sample data or to subscribe, kindly fill this form.